GILD Gilead Sciences PE ratio, current and historical analysis
As of Dec 20, 2024, the Gilead Sciences stock's PE ratio is 925.7. This results from the current EPS of $0.1 and stock price of $92.57. The current PE ratio is nearly equal to the average from the previous four quarters.
GILD PE ratio history
The PE ratio of Gilead Sciences has averaged 65.82 over the last ten years. The current PE ratio of 925.7 is comparable to the historical average. Over the past ten years, GILD's PE ratio was at its highest in the Sep 2024 quarter at 838.4, when the stock price was $83.84 and the EPS was $0.1. The lowest value was in the Dec 2016 quarter, when it reached 7.1 with a price of $71.61 and an EPS of $10.08.
Gilead Sciences PE ratio by year
Maximum annual increase: 3,700.39% in 2020
Maximum annual decrease: -97.49% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 17.84 | -23.96% |
| 2022 | 23.46 | 60.25% |
| 2021 | 14.64 | -97.49% |
| 2020 | 582.6 | 3,700.39% |
| 2019 | 15.33 | 2.96% |
| 2018 | 14.89 | -26.43% |
| 2017 | 20.24 | 185.07% |
| 2016 | 7.1 | -13.2% |
| 2015 | 8.18 | -31.03% |
| 2014 | 11.86 | -68.25% |
GILD average PE ratio chart
The current PE ratio of GILD is greater than its 3, 5 and 10-year historical averages.
GILD PE vs peers
Compared to its peer stocks LLY and JNJ, GILD's PE ratio stands higher. Gilead Sciences's current PE ratio of 925.7 is comparable to the average of its peer group, which is 38.47.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BIIB Biogen Inc | 13.18 | $21.34B |
| MRK Merck & Co Inc | 20.47 | $248.03B |
| JNJ Johnson & Johnson | 23.96 | $347.83B |
| AMGN Amgen Inc | 33.38 | $141.58B |
| PFE Pfizer Inc | 34.68 | $149.38B |
| ABBV AbbVie Inc | 60.97 | $310.27B |
| LLY ELI LILLY & Co | 82.64 | $728.85B |
| QGEN Qiagen NV | 120.73 | $10B |
| GILD Gilead Sciences Inc | 925.7 | $115.37B |
| VRTX Vertex Pharmaceuticals Inc | N/A | $102.31B |
| ILMN Illumina Inc | N/A | $21.57B |
Frequently asked questions
What is Gilead Sciences's PE ratio?
GILD stock has a price to earnings ratio of 925.7 as of Dec 20, 2024.
What is the 3-year average PE ratio for Gilead Sciences (GILD)?
Over the last 3 years, the average price to earnings ratio for GILD stock is 105.72.
What is the 5-year average PE ratio for Gilead Sciences (GILD)?
Over the last 5 years, the average price to earnings ratio for GILD stock is 117.75.
What is the highest PE ratio for GILD?
The current P/E of 925.7 represents the highest historical value in the last ten years.
How does the current PE ratio for GILD compare to its historical average?
GILD's price to earnings ratio is currently 1,306% above its 10-year historical average.
Why is Gilead Sciences's PE ratio so high?
A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.
How is GILD's PE ratio calculated (Gilead Sciences PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Dec 20, 2024), Gilead Sciences's stock price is $92.57. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.1. Therefore, Gilead Sciences's P/E ratio for today is 925.7. PE RATIO(925.7) = STOCK PRICE($92.57) / TTM EPS($0.1)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.